[The use of beta-1-adrenergic agonists in the treatment of cardiac insufficiency].
Adrenaline, noradrenaline, isoproterenol, dopamine, dobutamine and prenalterol, all stimulate ventricular contractility be increasing the cAMP. It is important to understand their cardiac and peripheral effects so that they can be used rationally. Over recent years, these drugs have changed the course of many patients, often in a critical state.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000242:Cyclic AMP / Q000378:metabolism; D004280:Dobutamine / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D009200:Myocardial Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000627:therapeutic use; D011217:Practolol / Q000031:analogs & derivatives / Q000627:therapeutic use; D011294:Prenalterol
D000318:Adrenergic beta-Agonists; D004280:Dobutamine; D000242:Cyclic AMP; D007545:Isoproterenol; D011294:Prenalterol; D011217:Practolol; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine
L'utilisation des agonistes adrènergiques bêta-1 dans le traitement de l'insuffisance cardiaque.